GE HealthCare Technologies Inc. will be attending the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting from June 21-24 at the New Orleans Ernest N. Morial Convention Center. At the event, the company will present its innovative portfolio of theranostics-enabling solutions, including the debut of LesionID™ Pro with automated zero-click pre-processing, an AI-powered tool designed to aid physician decision-making and therapy response monitoring.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250621431355) on June 21, 2025, and is solely responsible for the information contained therein.